McKesson Corporation (0JZU.L)

527,67 -4,12 (-0,77%) In data: 02:58PM BST. Mercato aperto.

McKesson Corporation

6555 State Highway 161
Irving, TX 75039
United States
972 446 4800
https://www.mckesson.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 45.000

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Brian S. Tyler Ph.D.	CEO & Director	7,22M	6,33M	1967
Mr. Britt J. Vitalone	Executive VP & CFO	3,04M	1,1M	1969
Ms. LeAnn B. Smith	Executive VP & Chief Human Resources Officer	1,32M	N/D	1975
Ms. Lori A. Schechter J.D.	Board & Enterprise Risk Advisor	2,6M	1,02M	1962
Mr. Napoleon B. Rutledge Jr.	Senior VP, Controller & Chief Accounting Officer	N/D	N/D	1972
Mr. Francisco Fraga	Executive VP, Chief Information Officer & Chief Technology Officer	N/D	N/D	1973
Rachel Rodriguez	Vice President of Investor Relations	N/D	N/D	N/D
Ms. Michele Lau	Executive VP & Chief Legal Officer	N/D	N/D	1977
Mr. Pete Slone	Senior Vice President of Corporate Public Affairs	N/D	N/D	N/D
Mr. Kirk Kaminsky	President of The US Pharmaceutical & Specialty Solutions Business	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in USD.

Descrizione

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment offers distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Governance aziendale

L'ISS Governance QualityScore di McKesson Corporation al 1 aprile 2024 è 3. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 1; diritti degli azionisti: 4; retribuzione: 4.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.